Cargando…
免疫治疗新浪潮下对中国肺癌免疫临床研究的审思
Starting from the success of anti-CTLA-4 antibody in malignant melanoma, targeted immunotherapy has become one of the effective strategies for anti-tumor therapy, and raised a new wave of research on tumor immunotherapy. In the field of lung cancer, a series of clinical studies on immune-targeted dr...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972995/ https://www.ncbi.nlm.nih.gov/pubmed/29061217 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.10.06 |
Ejemplares similares
-
肺癌的免疫治疗临床研究进展
Publicado: (2012) -
小细胞肺癌免疫治疗的临床研究进展
Publicado: (2020) -
新免疫治疗时代下复发难治性霍奇金淋巴瘤治疗新策略
Publicado: (2019) -
非小细胞肺癌新辅助免疫治疗生物标志物研究进展
Publicado: (2022) -
免疫检查点TIGIT在肺癌免疫治疗中的研究进展
Publicado: (2022)